The US FDA has recently proposed a new draft framework that enables pharma manufacturers to add software to a drug label if they can demonstrate that the software adds clinical benefit to the drug.

The Anchorage School District in Alaska admitted it made a "mistake" by adding a disclaimer saying that the school district "does not endorse these materials or the viewpoints expressed" on a flyer ...